Banque Pictet & Cie Sa Sage Therapeutics, Inc. Transaction History

Banque Pictet & Cie Sa

  • $13.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023
BUY
$37.27 - $46.57 $7,714 - $9,639
207 Added 1.03%
20,223 $848,000
Q4 2022

Feb 06, 2023
SELL
$32.2 - $43.61 $203,375 - $275,440
-6,316 Reduced 23.99%
20,016 $0
Q3 2022

Nov 10, 2022
BUY
$32.28 - $43.27 $849,996 - $1.14 Million
26,332 New
26,332 $1.03 Billion

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email